Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase.

Source:http://linkedlifedata.com/resource/pubmed/id/9815865

Circulation 1998 Nov 17 98 20 2117-25

Download in:

View as

General Info

PMID
9815865